TAC1 and Ventricular arrhythmia: On the basis of the model for hypokalemia-induced ventricular arrhythmias in Figure 2, we suggest CaMKII inhibition, NKA activation, and in particular NKAα2 activation, to be further investigated as future antiarrhythmic strategies.